(1)
MONITORING THE FREQUENCY OF ADVERSE EVENTS FOLLOWING VACCINATION UPTO 6-YEAR-OLD CHILDREN. Int. Res. J. Pharm. 2016, 7 (6), 128-132. https://doi.org/10.56802/7h2sfe36.